GrantRover ↗

← All opportunities

Food and Drug Administration · United States

Minor Use Minor Species Development of Drugs (R01)

Open

Food and Drug Administration expects to make awards of up to $250,000 each, from a total budget of $250,000. Applications close on 29 Jan 2027. Eligible applicant types include small businesses, independent school districts, special district governments and 12 more.

Deadline
29 Jan 2027 (in 75 days)
Grant amount
Up to $250,000 per project
Funding rate
No mandatory cost sharing stated; funding percentage not stated
Total budget
$250,000
Cost sharing
Not required
Likely applicant types
SMEs / start-ups, Companies, Public bodies, Universities & research, Non-profits From source categories or programme rules; the call decides.
Funder
Food and Drug Administration
Reference
PAR-24-216
Assistance listing
93.103 Food and Drug Administration Research
Last checked
13 Nov 2026

Open the official call ↗ Add deadline to calendar

About this call

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS).

The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs.

Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants.

The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.

Read the full text

FDA/CVM's Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.

Who can apply

• Faith-based or Community-based Organizations• Regional Organizations• Non-domestic (non-U.S.) Entities (Foreign Organizations)

Applicant categories are a starting point. The official call decides eligibility.

Topics

Agriculture Consumer Protection Food and Nutrition

Timing

Application Due Dates are as follows: July 29, 2024; January 31, 2025; July 25, 2025; January 30, 2026; July 24, 2026; January 29, 2027

How to apply

  1. Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
  2. Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
  3. Register with Grants.gov and set up a Workspace for this opportunity, with the right roles for your organisation.
  4. Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
  5. Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
Not stated in the call text we hold — check the official page
Where applicants must be based
Not stated in the call text we hold — check the official page
Where to apply
Not stated in the call text we hold — check the official page

Contact

Terrin Brown · terrin.brown@fda.hhs.gov · 2404027610

Where these facts come from

FactValueHow we knowTaken from the source
Deadline29 January 2027official data field15 Nov 2026
Amount per applicantUp to $250,000official data field15 Nov 2026
Total budget$250,000official data field15 Nov 2026
Funding rateNo mandatory cost sharing stated; funding percentage not statedread from the official text15 Nov 2026
Who can applySmall businesses; Independent school districts; Special district governments; Public housing authorities/Indian housing authorities; Private institutions of higher education; Public and State controlled institutions of…official data field15 Nov 2026
Where to applyUnknown — not stated in the source we holdunknown—

Official sources

Official call page · Funder's programme page

Facts on this page come from the funder’s official data, taken on 13 Nov 2026. The funder's own documents, including later amendments, always take precedence.

Related funding

Food and Drug Administration United States

Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies… (R01 Clinical Trials Optional)

RFA-FD-25-017

The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare d…

Food and Drug Administration United States

Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet… (R01 Clinical Trials Required)

RFA-FD-25-020

The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change…

U.S. National Science Foundation United States

Applied Mathematics

PD-16-1266

The Applied Mathematics program supports mathematics research motivated by and contributing to the solution of problems arising in science and engineering. Successful pro…

U.S. National Science Foundation United States

Astronomy and Astrophysics Research Grants

22-624

The Astronomy and Astrophysics Research Grants (AAG) Program is an inclusive and flexible funding opportunity to support research in the astronomical sciences. The Progra…

Defense Health Agency Contracting Activity - DHACA United States

DoW Joint Warfighter Medical, Military Medical Research and Development Award

HT942526JWMRPMMRDA

Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fu…